Assessment of patients affected by rheumatoid arthritis eligible for biotechnological agents and evaluation of their healthcare resource utilization and related costs
Submitted: 1 August 2020
Accepted: 15 February 2021
Published: 19 April 2021
Accepted: 15 February 2021
Abstract Views: 3476
PDF: 487
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- A.J.L. Ferrari, A.R. Corrêa Fernandes, R. de Almeida Agustinelli, H. Seike, E. de Ávila Fernandes, Tophi reduction: ultrasound imaging and correlation with plasma levels of uric acid in patients undergoing treatment for tophaceous gout , Reumatismo: Vol. 71 No. 2 (2019)
- A. Manzo, S. Bugatti, R. Caporali, C. Montecucco, Histopathology of the synovial tissue: perspectives for biomarker development in chronic inflammatory arthritides , Reumatismo: Vol. 70 No. 3 (2018): Monographic issue on Histopathology in Rheumatic Diseases
- F.M. Perrotta, S. Scriffignano, M. Fatica, M. Specchia, E. Lubrano, Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab , Reumatismo: Vol. 72 No. 3 (2020)
- V. Bruzzese, C. Marrese, P. Scolieri, J. Pepe, Psoriatic spondyloarthritis and Sjögren syndrome: a casual association? , Reumatismo: Vol. 72 No. 3 (2020)
- K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid, Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients? , Reumatismo: Vol. 71 No. 4 (2019)
- P. Falsetti, E. Conticini, C. Baldi, C. Acciai, R. D'Alessandro, M. Bardelli, L. Cantarini, B. Frediani, Observations about subcalcaneal adventitial bursitis (heel fat pad inflammatory lesion) in rheumatoid arthritis. Comment on the article of Suzuki and Shirai , Reumatismo: Vol. 72 No. 3 (2020)
- D. Rincón-Riaño, D.G. Fernández-Ávila, D. Acero-Molina, J.M. Bello Gualtero , C. Romero-Sánchez, Frequency of ANA/DFS70 autoantibodies in Colombian patients with undifferentiated connective tissue disease , Reumatismo: Vol. 74 No. 2 (2022)
- L. Fioravante da Silveira, A. Zago, D. Zanchet, D. Chemello, Macrophage activation syndrome in a patient with systemic lupus erythematosus undergoing cyclophosphamide treatment: a case report , Reumatismo: Vol. 75 No. 2 (2023)
- D. Diacinti, C. Gioia, F. Vullo, G. Cannavale, C. Catalano, G. Valesini, Magnetic resonance imaging findings of infectious sacroiliitis associated with iliopsoas abscess: a case report in a young male , Reumatismo: Vol. 70 No. 4 (2018)
- F.M. Perrotta, S. Scriffignano, A. De Socio, E. Lubrano, Occult axial involvement in patients with psoriatic arthritis mutilans: a case report , Reumatismo: Vol. 71 No. 2 (2019)
<< < 41 42 43 44 45 46 47 48 49 50 > >>
You may also start an advanced similarity search for this article.